472 related articles for article (PubMed ID: 9531051)
1. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced actin polymerization is required for the irreversibility of platelet aggregation.
Torti M; Festetics ET; Bertoni A; Sinigaglia F; Balduini C
Thromb Haemost; 1996 Sep; 76(3):444-9. PubMed ID: 8883284
[TBL] [Abstract][Full Text] [Related]
4. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
5. Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1.
Pula G; Poole AW
Platelets; 2008 May; 19(3):199-210. PubMed ID: 18432521
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
[TBL] [Abstract][Full Text] [Related]
7. ADP-induced platelet aggregation and actin polymerization. Involvement of GpIIb/IIIa and the effect of Mg2+.
Heptinstall S; Glenn JR; Lösche W; Spangenberg P
Semin Thromb Hemost; 1995; 21(2):137-45. PubMed ID: 7660136
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function.
Natarajan P; May JA; Sanderson HM; Zabe M; Spangenberg P; Heptinstall S
Platelets; 2000 Dec; 11(8):467-76. PubMed ID: 11177446
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
12. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
13. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
Chen YY; Kwan CY; Hui SC
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
[TBL] [Abstract][Full Text] [Related]
14. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.
George JN; Lyons RM; Morgan RK
J Clin Invest; 1980 Jul; 66(1):1-9. PubMed ID: 6772667
[TBL] [Abstract][Full Text] [Related]
15. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
16. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
Lee H; Paton RC; Ruan C; Caen JP
Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
[TBL] [Abstract][Full Text] [Related]
17. Changes in G-actin after platelet activation in platelet rich plasma.
Heptinstall S; Glenn J; Spangenberg P
Thromb Haemost; 1992 Dec; 68(6):727-30. PubMed ID: 1287889
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP.
Lee WM; Kim SD; Park MH; Cho JY; Park HJ; Seo GS; Rhee MH
J Pharm Pharmacol; 2008 Nov; 60(11):1531-6. PubMed ID: 18957175
[TBL] [Abstract][Full Text] [Related]
19. The mode of rabbit platelet shape change and aggregation induced by theonezolide-A, a novel polyketide macrolide, isolated from the Okinawan marine sponge Theonella sp.
Rho MC; Park YH; Sasaki S; Ishibashi M; Kondo K; Kobayashi J; Ohizumi Y
Can J Physiol Pharmacol; 1996 Feb; 74(2):193-9. PubMed ID: 8723032
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
Li BY; Bai Y; Li WH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]